Ask AI
APP BsAb in MM

CE

APP Perspectives: Safe and Effective Use of Bispecific Antibodies in Multiple Myeloma

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 0.50 Nursing contact hour

Released: November 17, 2025

Expiration: May 16, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

In your discussion with a patient and his wife, which of the following bispecific antibodies would you tell them allows for biweekly dosing immediately after completing step-up dosing?

2.

As you are finalizing safety protocols for bispecific antibodies with your team, which of the following steps is most essential to include in your outpatient workflow to ensure safe management of potential cytokine-release syndrome (CRS)?